Effect of stress-induced hyperglycaemia on clinical outcome in paitients with acute ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention - Report - MDSpire

Effect of stress-induced hyperglycaemia on clinical outcome in paitients with acute ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention

  • By

  • Kaidong Zeng

  • Zhixiong Liao

  • Yanming Du

  • Jianping Ding

  • May 14, 2026

  • 0 min

Share

Impact of Stress-Induced Hyperglycemia on Clinical Outcomes in STEMI Patients

Overview

This study investigates the impact of stress hyperglycemia (SHG) on clinical outcomes in patients with acute ST-segment elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI). SHG is identified as a significant independent risk factor for in-hospital mortality and long-term adverse outcomes, emphasizing the need for early risk stratification.

Background

Stress hyperglycemia is a transient glycemic disturbance that occurs during acute stress, such as myocardial infarction. Its prognostic significance in STEMI patients undergoing PCI is not fully understood, despite evidence linking it to worse outcomes. Understanding SHG's role can enhance risk stratification and management strategies in this high-risk population.

Data Highlights

GroupIn-Hospital MortalityOne-Year MortalityHeart Failure Incidence
SHG (n=200)13.4%14.9%26.0%
Non-SHG (n=319)2.19%3.76%12.23%

Key Findings

  • SHG is associated with significantly higher in-hospital all-cause mortality (13.4% vs. 2.19%, P < 0.001).
  • Multivariate analysis identifies SHG as the strongest independent risk factor for in-hospital mortality (OR = 4.68).
  • At one year, SHG patients exhibit higher mortality (14.9% vs. 3.76%) and heart failure incidence (26.0% vs. 12.23%).
  • Long-term mortality is primarily influenced by Killip classification and coronary artery disease severity.
  • SHG should be incorporated into early risk stratification for STEMI patients.

Clinical Implications

Clinicians should recognize SHG as a critical factor in assessing the prognosis of STEMI patients undergoing PCI. Early identification of SHG can facilitate tailored management strategies to improve outcomes in this vulnerable population.

Conclusion

The findings underscore the importance of monitoring stress hyperglycemia in STEMI patients, as it significantly impacts both short- and long-term clinical outcomes. Further research is warranted to elucidate the mechanisms underlying this association.

Related Resources & Content

  1. Frontiers in Cardiovascular Medicine, 2026 -- Impact of hypoglycemic regimens on cardiac recovery and quality of life after PCI in elderly AMI patients
  2. Clinical Research in Cardiology, 2025 -- Effects of Diabetes on Clinical Outcomes in Patients with ST-Elevation Myocardial Infarction and Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
  3. Clinical Research in Cardiology, 2022 -- Response to: Correlation of Admission Stress Hyperglycemia with Adverse Neurological Outcomes in OHCA Patients Undergoing ECPR
  4. Clinical Research in Cardiology, 2025 -- Long-term Outcomes in Diabetic Patients Following Percutaneous Coronary Intervention for In-Stent Restenosis: A Ten-Year Review
  5. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes - American College of Cardiology
  6. Frontiers, 2024 -- Stress hyperglycemia and poor outcomes in patients with ST-elevation myocardial infarction: a systematic review and meta-analysis
  7. Prognostic value of stress hyperglycemia ratio in patients with acute myocardial infarction: A systematic review with Bayesian and frequentist meta-analysis - ScienceDirect
  8. 2025 ACC/AHA Guideline for Acute Coronary Syndromes
  9. Frontiers | Stress hyperglycemia and poor outcomes in patients with ST-elevation myocardial infarction: a systematic review and meta-analysis
  10. Prognostic value of stress hyperglycemia ratio in patients with acute myocardial infarction: A systematic review with Bayesian and frequentist meta-analysis - ScienceDirect

Original Source(s)

Related Content